Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 4/20 | 0.56 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.55 |
| ▸ | GHSR | Q92847 | 2/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.53 |
| ▸ | ACE | P12821 | 2/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | BACE1 | P56817 | 1/20 | 0.52 |
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30724706 | 0.92 | ACE (0.62) | ACE | |
| SCHEMBL29872185 | 0.90 | KISS1R (0.58) | KISS1RERBB2GHSRACELTA4H | |
| SCHEMBL29550892 | 0.90 | GHSR (0.62) | KISS1RGHSR | |
| SCHEMBL29425599 | 0.89 | KISS1R (0.57) | KISS1RERBB2OPRM1OPRD1 | |
| SCHEMBL30495788 | 0.89 | KISS1R (0.60) | KISS1R | |
| SCHEMBL30799826 | 0.89 | GHSR (0.57) | GHSROPRM1OPRD1ACELTA4H | |
| SCHEMBL29425581 | 0.89 | KISS1R (0.59) | KISS1ROPRM1OPRD1 | |
| SCHEMBL29851151 | 0.88 | ACE (0.57) | ACEMAGI3 | |
| SCHEMBL30799534 | 0.88 | BACE1 (0.62) | BACE1 | |
| SCHEMBL30518959 | 0.87 | MAGI3 (0.59) | KISS1RERBB2GHSRMAGI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | PARABILIS MEDICINES, INC. | 2024-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | CTNNB1, APC, CTNNA1 | KISS1R 2859/4885ERBB2 1101/4885GHSR 1194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.